Last week we were delighted to host our 15th Investor Forum at the offices of DAC Beachcroft. We welcomed 4 interesting companies to present to an audience of 60 sophisticated investors. The audience had the opportunity to learn more about investing in clean energy, a dividend paying gold miner, and two distinct health care companies at different commercial stages.

Shield Therapeutics Viatris deal has the potential to accelerate sales at a much faster rate (LON:STX)
Hardman and Co’s Dr Martin discusses Shield Therapeutics plc in this exclusive interview with DirectorsTalk.